Akari Therapeutics, Plc (AKTX)

NASDAQ: AKTX · Real-Time Price · USD

15.07

-0.77 (-4.86%)

At close: Jun 5, 2026, 4:00 PM EDT

15.50

+0.43 (2.85%)

After-hours: Jun 5, 2026, 7:36 PM EDT

Akari Therapeutics, Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Akari Therapeutics, stock have an average target of $26.78, which predicts a 77.70% increase from the current stock price of 15.07.

Price Target: $26.78 (+77.70%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$26.78	$26.78	$26.78	$26.78
Change	+77.70%	+77.70%	+77.70%	+77.70%

* Price targets were last updated on Apr 21, 2026.

Analyst Ratings

The average analyst rating for Akari Therapeutics, stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	3	2	2	1
Buy	1	1	1	1	0	0
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	3	3	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sean Lee CFA H.C. Wainwright	H.C. Wainwright	Buy Reiterates $27	Buy	Reiterates	$27	+79.16%	Apr 21, 2026
Jason McCarthy Maxim Group	Maxim Group	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Apr 8, 2026
Aydin Huseynov Ladenburg Thalmann & Co.	Ladenburg Thalmann & Co.	Buy Initiates $40	Buy	Initiates	$40	+165.43%	Jan 5, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-12.00

EPS Next Year

-14.00

from -12.00

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-17.21M	-23.09M	-16.81M	-16.65M	-12.10M	-15.20M
Net Income	-17.42M	-17.75M	-10.01M	-19.79M	-17.30M	-15.20M
EPS	-	-	-	-	-	-12.00
Free Cash Flow	-11.31M	-6.04M	-16.74M	3.91M	-10.22M	-15.00M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-12.00
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-